Insider · CIK 0001315018

Maccecchini Maria-Luisa

Reports to the SEC for 3 companies · DALLAS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001315018

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-09	LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.2K sh	—	—	21,152
2026-01-09	LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2025-10-28	ANVSAnnovis Bio, Inc.P Purchase	Director, President & CEO	PPurchase	+97.6K sh	$2.05	+$200K	1,212,020
2025-06-04	ANVSAnnovis Bio, Inc.A Award	Director, President & CEO	AAward	+46K sh	$3.37	+$155K	1,114,459
2024-07-15	LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-03-31	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−10K sh	—	—	1,068,459
2024-03-31	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−10K sh	—	—	1,078,459
2024-03-28	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−10K sh	—	—	1,088,459
2023-11-20	ANVSAnnovis Bio, Inc.A Award	Director, President & CEO	AAward	+41K sh	$6.10	+$250K	1,098,459
2023-11-20	ANVSAnnovis Bio, Inc.A Award	Director, President & CEO	AAward	+41.2K sh	$6.07	+$250K	1,098,675
2023-11-17	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+109K sh	—	—	108,800
2023-11-17	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+252K sh	—	—	252,000
2023-04-24	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−3,000 sh	—	—	1,057,489
2023-04-07	ANVSAnnovis Bio, Inc.A Award	Director, President & CEO	AAward	+20K sh	$12.61	+$252K	1,060,489
2023-02-06	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−52.8K sh	—	—	0
2023-02-06	ANVSAnnovis Bio, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+52.8K sh	$0.14	+$7,385.7	1,040,489
2023-01-18	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+21.3K sh	—	—	21,312
2022-10-20	LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,200 sh	—	—	3,200
2022-01-14	ANVSAnnovis Bio, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+33K sh	$0.14	+$4,614.26	987,734
2022-01-14	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−33K sh	—	—	52,755
2022-01-03	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+83.4K sh	—	—	83,400
2022-01-03	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+19.9K sh	—	—	19,894
2021-12-20	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−20K sh	—	—	954,775
2021-12-06	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+145K sh	—	—	145,305
2021-12-06	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+113K sh	—	—	112,995
2021-10-11	ANVSAnnovis Bio, Inc.P Purchase	Director, President & CEO	PPurchase	+18K sh	$27.61	+$497K	976,775
2021-07-07	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+41.7K sh	—	—	41,700
2021-07-01	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−1,000 sh	—	—	974,775
2021-07-01	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−1,000 sh	—	—	975,775
2020-07-15	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−10K sh	—	—	976,775
2020-04-27	ANVSAnnovis Bio, Inc.G Gift	Director, President & CEO	GGift	−10K sh	—	—	986,775
2020-04-09	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director, President & CEO	AAward	+300K sh	—	—	300,000
2020-01-31	ANVSAnnovis Bio, Inc.C Conversion	Director, President & CEO	CConversion	+7,937 sh	—	—	215,879
2020-01-31	ANVSAnnovis Bio, Inc.C Conversion	Director, President & CEO	CConversion	+763K sh	—	—	978,775
2020-01-31	ANVSAnnovis Bio, Inc. · Series A-1 Preferred StockC Conversion	Director, President & CEO	CConversion	−11.1K sh	—	—	0
2020-01-31	ANVSAnnovis Bio, Inc. · Series A Preferred StockC Conversion	Director, President & CEO	CConversion	−1.07M sh	—	—	0
2020-01-31	ANVSAnnovis Bio, Inc.P Purchase	Director, President & CEO	PPurchase	+1,600 sh	$6.00	+$9,600	207,942
2006-01-04	CALMARE THERAPEUTICS IncA Award	Director	AAward	+2,500 sh	—	—	2,500
2006-01-04	CALMARE THERAPEUTICS IncP Purchase	Director	PPurchase	+1,800 sh	$4.00	+$7,200	4,500
2006-01-04	CALMARE THERAPEUTICS IncP Purchase	Director	PPurchase	+200 sh	$3.98	+$796	2,700
2006-01-03	CALMARE THERAPEUTICS IncOption - Right to BuyA Award	Director	AAward	+10K sh	—	—	10,000
2005-01-14	CALMARE THERAPEUTICS IncOption (right to buy common stock)A Award	Director	AAward	+10K sh	—	—	10,000
2005-01-14	CALMARE THERAPEUTICS IncOption (right to buy common stock)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jan 134
Maccecchini Maria-Luisa0001493152-26-002025
SEC(opens sec.gov)
Nov 124
Maccecchini Maria-Luisa0001104659-25-109906
SEC(opens sec.gov)
Jun 54
Maccecchini Maria-Luisa0001104659-25-056578
SEC(opens sec.gov)
Jul 174
Maccecchini Maria-Luisa0001493152-24-028185
SEC(opens sec.gov)
Jul 34
Maccecchini Maria-Luisa0001104659-24-077834
SEC(opens sec.gov)
Nov 224/A
Maccecchini Maria-Luisa0001104659-23-120762
SEC(opens sec.gov)
Nov 214
Maccecchini Maria-Luisa0001104659-23-120302
SEC(opens sec.gov)
Apr 264
Maccecchini Maria-Luisa0001104659-23-050393
SEC(opens sec.gov)
Apr 114
Maccecchini Maria-Luisa0001104659-23-044202
SEC(opens sec.gov)
Feb 84
Maccecchini Maria-Luisa0001104659-23-014610
SEC(opens sec.gov)
Jan 204
Maccecchini Maria-Luisa0001104659-23-005481
SEC(opens sec.gov)
Oct 244
Maccecchini Maria-Luisa0001493152-22-029456
SEC(opens sec.gov)
Jan 184
Maccecchini Maria-Luisa0001104659-22-005059
SEC(opens sec.gov)

Companies

Address

1920 MCKINNEY AVENUE, 7TH FLOOR

DALLAS, TX, 75201